SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SEAN007 who wrote (326)5/12/1999 7:57:00 PM
From: Roger Cranwill  Read Replies (2) of 656
 
Re: 6 deaths reported with Enbrel
Its interesting, the very same thing was reported with another stock I owned-IDEC (IDPH) their Non-Hodgkin's Lymphoma drug Rituxan was reported to have caused deaths attributed to an anaphylactic shock reaction. I panicked and immediately sold all my shares the next day (at 33)-the stock kept moving up and never looked back (its now at 57+). It taught me a valuable lesson-wait a while till the smoke clears...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News